| 英文名称 | 中文名称 | CAS | MF |
|
5H-Cyclopenta[b]pyridine-6-methanol,6,7-dihydro-,(6R)-(9CI)
|
|
591768-73-9
|
C9H11NO
|
|
3-Cyclopentylacrylonitrile
|
3-环戊基丙烯腈
|
591769-05-0
|
C8H11N
|
|
(6-ethoxypyridin-3-yl)methylamine
|
591771-82-3
|
591771-82-3
|
C8H12N2O
|
|
8-Ethyl-1,4,7,8-tetrahydro-4-methyl-2-(2,3,5-trichlorophenyl)-5H-imidazo[2,1-i]purin-5-one monohydrochloride
|
化合物 T23198
|
591771-91-4
|
C16H14Cl3N5O.ClH
|
|
Omnicat 550
|
10-(4-联苯基)-2-异丙基噻吨酮-10-硫鎓六氟磷酸盐
|
591773-92-1
|
C28H23F6OPS
|
|
5(4H)-Oxazolone, 4-(1-methylethyl)-2-[4-(trifluoromethyl)phenyl]-
|
|
591774-74-2
|
C13H12F3NO2
|
|
3-(4-Mercapto-2-Methyl-phenyl)-propionic acid Methyl ester
|
|
591775-09-6
|
C11H14O2S
|
|
Ethyl 2-phenylamino-5-thiazolecarboxylate
|
|
591777-89-8
|
C12H12N2O2S
|
|
CP 640186
|
(R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL
|
591778-68-6
|
C30H35N3O3
|
|
CP-640186 (hydrochloride)
|
盐酸CP-640186
|
591778-70-0
|
C30H36ClN3O3
|
|
Morpholine, 3,5-diMethyl-, (3R,5R)-
|
3R,5R-二甲基吗啉
|
591779-91-8
|
C6H13NO
|
|
1-Pyrrolidin-3-yl-piperidine
|
|
591781-02-1
|
C12H22N2O2
|
|
1H-Indole,2-(1,1-dimethylethyl)-7-ethyl-2,3-dihydro-(9CI)
|
|
592465-75-3
|
C14H21N
|
|
1H-Indole,2-cyclopentyl-7-ethyl-2,3-dihydro-(9CI)
|
|
592465-77-5
|
C15H21N
|
|
1H-Indole,7-fluoro-2,3-dihydro-2-(2-pyridinyl)-(9CI)
|
|
592465-98-0
|
C13H11FN2
|
|
1H-Indole,7-fluoro-2,3-dihydro-2-(3-pyridinyl)-(9CI)
|
|
592465-99-1
|
C13H11FN2
|
|
1H-Indole,7-fluoro-2,3-dihydro-2-(4-pyridinyl)-(9CI)
|
|
592466-00-7
|
C13H11FN2
|
|
1H-Indole,2,3-dihydro-7-(1-methylethyl)-2-(2-pyridinyl)-(9CI)
|
|
592466-50-7
|
C16H18N2
|
|
1H-Indole,2,3-dihydro-7-(1-methylethyl)-2-(3-pyridinyl)-(9CI)
|
|
592466-51-8
|
C16H18N2
|
|
1H-Indole,2,3-dihydro-7-(1-methylethyl)-2-(4-pyridinyl)-(9CI)
|
|
592466-52-9
|
C16H18N2
|
|
2-Methyl-4-nitro-5-piperazin-1-yl-phenylamine
|
(2-甲基-4-硝基-5-哌嗪-1-基-苯基)胺
|
592466-87-0
|
C11H16N4O2
|
|
(E)-3-(3-Methoxy-2-propoxy-phenyl)-acrylic acid
|
3-(3-Methoxy-2-propoxyphenyl)-2-propenoic acid
|
592467-83-9
|
C13H16O4
|
|
N-(4-Chloro-2-Methylphenyl)-4-fluorobenzaMide, 96%
|
N-(4-氯-2-甲基苯)-4-氟苯甲酰胺
|
592471-25-5
|
C14H11ClFNO
|
|
4-[(2-chlorobenzyl)-mesyl-amino]benzoic acid
|
4-[(2-氯苄基)-甲磺酰基-氨基]苯甲酸
|
592472-66-7
|
C15H14ClNO4S
|
|
[4-(1-adamantyl)(methylsulfonyl)anilino]acetic acid
|
[4-(1-金刚烷基)(甲基磺酰基)苯胺基]乙酸
|
592473-65-9
|
C19H25NO4S
|
|
4-[4-keto-3-(2-phenylethyl)thiazolidin-2-yl]benzoic acid
|
4-[4-氧代-3-(2-苯基乙基)四氢噻唑-2-基]苯甲酸
|
592473-77-3
|
C18H17NO3S
|
|
2-Chloro-4-[5-[[2-[(ethylamino)thioxomethyl]hydrazinylidene]methyl]-2-furanyl]benzoic acid
|
2-Chloro-4-[5-[[2-[(ethylamino)thioxomethyl]hydrazinylidene]methyl]-2-furanyl]benzoic acid
|
592474-91-4
|
C15H14ClN3O3S
|
|
2(1H)-Pyrimidinone,5-fluoro-4-(methylamino)-,hydrazone(9CI)
|
|
592477-24-2
|
C5H8FN5
|
|
1(2H)-Pyridineaceticacid,3-cyano-4-(hydroxymethyl)-6-methyl-2-oxo-,hydrazide(9CI)
|
|
592477-25-3
|
C10H12N4O3
|
|
3-Methyl-2-aza-spiro[4.5]decane
|
|
592478-37-0
|
C10H19N
|
|
Pyrrolidine, 1-ethyl-2,4,4-trimethyl- (9CI)
|
|
592478-39-2
|
C9H19N
|
|
N-[2-(2,2-DiMethoxy-ethyl)-phenyl]-forMaMide
|
|
592478-96-1
|
C11H15NO3
|
|
1-(2,2-DiMethoxy-ethyl)-2-isocyano-benzene
|
|
592479-02-2
|
C11H13NO2
|
|
Quinoline, 3-methoxy-7-methyl- (9CI)
|
|
592479-08-8
|
C11H11NO
|
|
Quinoline, 3-methoxy-6-methyl- (9CI)
|
|
592479-09-9
|
C11H11NO
|
|
Cyclopentanecarboxylic acid, 2-(acetylamino)-, ethyl ester, (1S,2R)- (9CI)
|
|
592503-39-4
|
C10H17NO3
|
|
Cyclopentanecarboxylic acid, 2-(acetylamino)-, ethyl ester, (1R,2S)- (9CI)
|
|
592503-41-8
|
C10H17NO3
|
|
1-Cyclopentene-1-carboxylic acid, 2-(acetylamino)-, methyl ester
|
|
592503-43-0
|
C9H13NO3
|
|
(R)-2,4,6-Triisopropylbenzenesulfinamide
|
(R)-2,4,6-三异丙基苯亚磺酰胺
|
592507-77-2
|
C15H25NOS
|
|
Benzeneacetic acid, 3-fluoro--alpha-,4-dihydroxy-, methyl ester (9CI)
|
|
592508-28-6
|
C9H9FO4
|
|
D-Iditol, 1,6-dideoxy-1,6-epithio-3,4-O-(1-methylethylidene)- (9CI)
|
|
592517-47-0
|
C9H16O4S
|
|
NFAT inhibitor, Cell Permeable
|
NFAT抑制剂,可渗透细胞
|
592517-80-1
|
C147H259N67O36S
|
|
ba-L-Ribopyranoside, methyl 4-thio-, 4-acetate (9CI)
|
|
592524-00-0
|
C8H14O5S
|
|
6H-Furo[3,4-c]pyrazol-6-one,3,3a,4,6a-tetrahydro-4-methoxy-3-methyl-,(3R,3aR,4R,6aS)-rel-(9CI)
|
|
592524-36-2
|
C7H10N2O3
|
|
6H-Furo[3,4-c]pyrazol-6-one,3,3a,4,6a-tetrahydro-4-methoxy-3-methyl-,(3R,3aS,4S,6aR)-rel-(9CI)
|
|
592524-37-3
|
C7H10N2O3
|
|
6H-Furo[3,4-c]pyrazol-6-one,3,3a,4,6a-tetrahydro-4-methoxy-3-methyl-,(3R,3aR,4S,6aS)-rel-(9CI)
|
|
592524-38-4
|
C7H10N2O3
|
|
4H-Furo[3,4-c]pyrazol-4-one,3,3a,6,6a-tetrahydro-6-methoxy-3-methyl-,(3R,3aR,6S,6aS)-rel-
|
|
592524-39-5
|
C7H10N2O3
|
|
4H-Furo[3,4-c]pyrazol-4-one,3,3a,6,6a-tetrahydro-6-methoxy-3-methyl-,(3R,3aS,6R,6aR)-rel-
|
|
592524-40-8
|
C7H10N2O3
|
|
(E)-tert-butyl 3-(4-((N-(3-((E)-3-methoxy-3-oxoprop-1-enyl)phenyl)cyclohexanecarboxamido)methyl)phenyl)acrylate
|
FEXARAMATE
|
592524-75-9
|
C31H37NO5
|
|
(E)-methyl 3-(3-(cyclohexanecarboxamido)phenyl)acrylate
|
3-[3-[(环己基羰基)氨基]苯基]-2-丙烯酸甲酯
|
592524-89-5
|
C17H21NO3
|
|
(E)-methyl 3-(3-(N-(4-bromobenzyl)cyclohexanecarboxamido)phenyl)acrylate
|
|
592524-95-3
|
C24H26BrNO3
|
|
4-Benzofuranaceticacid,7-ethyl-2,3,3a,4,7,7a-hexahydro-2-oxo-,(3aR,4S,7S,7aS)-rel-(9CI)
|
|
592526-38-0
|
C12H16O4
|
|
2(3H)-Benzofuranone,7-ethyl-3a,4,7,7a-tetrahydro-4-(2-hydroxyethyl)-,(3aR,4S,7S,7aS)-rel-(9CI)
|
|
592526-42-6
|
C12H18O3
|
|
3-(o-Tolyl)-8-azabicyclo[3.2.1]octane HCl
|
|
592527-86-1
|
C14H20ClN
|
|
Benzene, 1-fluoro-4-(1E)-1-pentenyl- (9CI)
|
|
592527-97-4
|
C11H13F
|
|
3a,7a-Methano-1H-indene-8,8-dimethanol,2,3-dihydro-(9CI)
|
|
592528-73-9
|
C12H16O2
|
|
2H-1-Benzopyran,3-fluorooctahydro-,(4aR,8aS)-rel-(9CI)
|
|
592530-38-6
|
C9H15FO
|
|
(3aS,4R,6S,6aR)-6-AMinotetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-ol
|
(3AS,4R,6S,6AR)-6-氨基四氢-2,2-二甲基-4H-环戊烯并-1,3-二氧杂环戊烷-4-醇
|
592533-90-9
|
C8H15NO3
|
|
4-Imidazolidinone,3-propyl-2-thioxo-5-[(1,2,5-trimethyl-1H-pyrrol-3-yl)methylene]-(9CI)
|
|
592536-07-7
|
C14H19N3OS
|
|
(3β,20S)-4,4,20-Trimethyl-pregna-5,7-diene-3,21-diol 3-Benzoate
|
(3β,20S)-4,4,20-Trimethyl-pregna-5,7-diene-3,21-diol 3-Benzoate
|
592536-32-8
|
C31H42O3
|
|
4-Imidazolidinone,5-[(7-ethyl-1H-indol-3-yl)methylene]-3-methyl-2-thioxo-(9CI)
|
|
592536-44-2
|
C15H15N3OS
|
|
5-Methyl-4-(3-methylphenyl)-4H-1,2,4-triazole-3-thiol
|
5-甲基-4-(3-甲基苯基)-4H-1,2,4-三唑-3-基氢硫化物
|
592537-77-4
|
C10H11N3S
|
|
Cyclohexanecarboxylic acid, 3,5-diamino-, (1alpha,3alpha,5alpha)- (9CI)
|
Cyclohexanecarboxylic acid, 3,5-diamino-, (1alpha,3alpha,5alpha)- (9CI)
|
592537-89-8
|
C7H14N2O2
|
|
4-[(Z)-{3-[2-(morpholin-4-yl)-2-oxoethyl]-2,4-dioxo-1,3-thiazolidin-5-ylidene}methyl]benzoic acid
|
|
592539-36-1
|
C17H16N2O6S
|
|
(E)-2',4',6'-triMethoxystyryl-4-Methoxy-3-aMinobenzylsulfone, (E)-5-((2,4,6-triMethoxystyrylsulfonyl)Methyl)-2-MethoxybenzeneaMine
|
(E)-2-甲氧基-5 - (((2,4,6-三甲氧基甲酰基)磺酰基)甲基)苯胺
|
592542-50-2
|
C19H23NO6S
|
|
4-Methoxy-3-nitrobenzylsulfonylacetic acid
|
3-硝基-4-甲氧基苄基磺酰基乙酸
|
592542-51-3
|
C10H11NO7S
|
|
(E)-2,4,6-TriMethoxystyryl 4-Methoxy-3-Nitrobenzyl sulfone
|
(E)-1,3,5-三甲氧基-2-(2 - ((4-甲氧基-3-硝基苄基)磺酰基)乙烯基)苯
|
592542-52-4
|
C19H21NO8S
|
|
(2-Methoxy-5-[2-(2,4,6-trimethoxy-phenyl)-ethenesulfonylmethyl]-phenylamino)-acetic acid, sodium salt
|
瑞格色替
|
592542-59-1
|
C21H25NO8S
|
|
Rigosertib sodium
|
瑞格色替钠
|
592542-60-4
|
C21H24NNaO8S
|
|
(E)-Methyl 2-(2-Methoxy-5-((2′,4′,6′-triMethoxystyrylsulfonyl)Methyl)phenylaMino)acetate
|
(E) - 2 - ((2-甲氧基-5 - (((2,4,6-三甲氧基苯乙烯基)磺酰基)甲基)苯基)
|
592542-61-5
|
C22H27NO8S
|
|
MCA-Gly-Ser-Pro-Ala-Phe-Leu-Ala-Lys(Dnp)-D-Arg-NH2
|
MCA-GLY-SER-PRO-ALA-PHE-LEU-ALA-LYS(DNP)-D-ARG-NH2
|
592544-81-5
|
C61H82N16O18
|
|
1H-Indole-1-acetamide,3-formyl-N-2-pyridinyl-(9CI)
|
|
592546-17-3
|
C16H13N3O2
|
|
1H-Indole-1-acetamide,3-formyl-N-(2-methylphenyl)-(9CI)
|
|
592546-19-5
|
C18H16N2O2
|
|
N-(2,5-Dimethyl-phenyl)-2-(3-formyl-indol-1-yl)-acetamide
|
|
592546-20-8
|
C19H18N2O2
|
|
2-(3-Formyl-indol-1-yl)-N-(4-iodo-phenyl)-acetamide
|
2-(3-甲酰基-1H-吲哚-1-基)-N-(4-碘苯基)乙酰胺
|
592546-22-0
|
C17H13IN2O2
|
|
1H-Indole-1-acetamide,N-(2-fluorophenyl)-3-formyl-(9CI)
|
|
592546-38-8
|
C17H13FN2O2
|
|
1H-Indole-1-acetamide,N-cyclohexyl-3-formyl-(9CI)
|
|
592546-44-6
|
C17H20N2O2
|
|
1H-Indole-1-acetamide,3-formyl-N-(2-methylcyclohexyl)-(9CI)
|
|
592546-45-7
|
C18H22N2O2
|
|
1H-Indole-1-acetamide,3-formyl-N-(5-methyl-2-thiazolyl)-(9CI)
|
|
592546-46-8
|
C15H13N3O2S
|
|
1H-Indole-1-acetamide,3-formyl-N-2-thiazolyl-(9CI)
|
|
592546-54-8
|
C14H11N3O2S
|
|
2-(3-Formyl-indol-1-yl)-N-(2-methoxy-phenyl)-acetamide
|
2-(3-甲酰基-1H-吲哚-1-基)-N-(2-甲氧基苯基)乙酰胺
|
592546-58-2
|
C18H16N2O3
|
|
1H-Indole-1-acetamide,3-formyl-N-(3-methyl-2-pyridinyl)-(9CI)
|
|
592546-63-9
|
C17H15N3O2
|
|
N-(3-Chloro-phenyl)-2-(3-formyl-indol-1-yl)-acetamide
|
|
592546-67-3
|
C17H13ClN2O2
|
|
Benzoic acid, 4-[(3-formyl-1H-indol-1-yl)methyl]- (9CI)
|
|
592546-71-9
|
C17H13NO3
|
|
Benzoic acid, 4-[(3-formyl-1H-indol-1-yl)methyl]-, methyl ester (9CI)
|
|
592546-73-1
|
C18H15NO3
|
|
1H-Indole-1-acetamide,3-formyl-N-(6-methyl-2-pyridinyl)-(9CI)
|
|
592546-74-2
|
C17H15N3O2
|
|
2-[2-(3-Formyl-indol-1-yl)-acetylamino]-benzoic acid methyl ester
|
2-(2-(3-甲酰-1H-吲哚-1-基)乙酰胺基)苯甲酸甲酯
|
592546-80-0
|
C19H16N2O4
|
|
Piperazine, 1-[(3-formyl-1H-indol-1-yl)acetyl]-4-methyl- (9CI)
|
|
592546-82-2
|
C16H19N3O2
|
|
1H-Indole-1-acetamide,3-formyl-2-methyl-N-2-pyridinyl-(9CI)
|
|
592549-71-8
|
C17H15N3O2
|
|
1H-Indole-1-acetamide,3-formyl-2-methyl-N-2-thiazolyl-(9CI)
|
|
592550-10-2
|
C15H13N3O2S
|
|
1H-Indole-1-acetamide,3-formyl-2-methyl-N-phenyl-(9CI)
|
|
592550-30-6
|
C18H16N2O2
|
|
1H-Indole-3-carboxaldehyde,2-methyl-1-[(3-nitrophenyl)methyl]-(9CI)
|
|
592550-33-9
|
C17H14N2O3
|
|
1H-Indole-3-carboxaldehyde,2-methyl-1-[(2-nitrophenyl)methyl]-(9CI)
|
|
592550-34-0
|
C17H14N2O3
|
|
Benzoic acid, 4-[(3-formyl-2-methyl-1H-indol-1-yl)methyl]- (9CI)
|
|
592550-35-1
|
C18H15NO3
|
|
1H-Indole-3-carboxaldehyde,2-methyl-1-(1-methylethyl)-(9CI)
|
|
592550-38-4
|
C13H15NO
|
|
1H-Indole-3-carboxaldehyde,2-methyl-1-[(4-methylphenyl)methyl]-(9CI)
|
2-甲基-1-[(4-甲基苯基)甲基]-1H-吲哚-3-甲醛
|
592550-44-2
|
C18H17NO
|
|
1H-Indole-3-carboxaldehyde,2-methyl-1-[(3-methylphenyl)methyl]-(9CI)
|
2-甲基-1-(3-甲基苄基)-1H-吲哚-3-甲醛
|
592550-45-3
|
C18H17NO
|
|
1H-Indole-3-carboxaldehyde,2-methyl-1-propyl-(9CI)
|
|
592550-46-4
|
C13H15NO
|
|
Piperazine, 1-[(3-formyl-2-methyl-1H-indol-1-yl)acetyl]-4-methyl- (9CI)
|
|
592550-50-0
|
C17H21N3O2
|
|
2,2'-di(9H-carbazol-9-yl)-1,1'-biphenyl
|
2,2'-二(9咔唑)联苯
|
592551-54-7
|
C36H24N2
|